The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Abdominal Aortic Aneurysm Treatment Market Research Report 2025
Synopsis
The walls of the aorta can swell or bulge out like a small balloon if they become weak is called an abdominal aortic aneurysm (AAA) when it happens in the part of the aorta that’s in your abdomen.
The global Abdominal Aortic Aneurysm Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Abdominal Aortic Aneurysm Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Abdominal Aortic Aneurysm Treatment.
Report Scope
The Abdominal Aortic Aneurysm Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Abdominal Aortic Aneurysm Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Abdominal Aortic Aneurysm Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
AbbVie
Amgen
Pfizer
Aortica
Medtronic
Gore
CVT
Cardinal Health
Jotec
Segment by Type
Drug
Surgical Equipment
Segment by Application
Small (less than 5.5 centimeters)
Large (greater than 5.5 centimeters)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Abdominal Aortic Aneurysm Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The walls of the aorta can swell or bulge out like a small balloon if they become weak is called an abdominal aortic aneurysm (AAA) when it happens in the part of the aorta that’s in your abdomen.
The global Abdominal Aortic Aneurysm Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Abdominal Aortic Aneurysm Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Abdominal Aortic Aneurysm Treatment.
Report Scope
The Abdominal Aortic Aneurysm Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Abdominal Aortic Aneurysm Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Abdominal Aortic Aneurysm Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
AbbVie
Amgen
Pfizer
Aortica
Medtronic
Gore
CVT
Cardinal Health
Jotec
Segment by Type
Drug
Surgical Equipment
Segment by Application
Small (less than 5.5 centimeters)
Large (greater than 5.5 centimeters)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Abdominal Aortic Aneurysm Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Abdominal Aortic Aneurysm Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Drug
1.2.3 Surgical Equipment
1.3 Market by Application
1.3.1 Global Abdominal Aortic Aneurysm Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Small (less than 5.5 centimeters)
1.3.3 Large (greater than 5.5 centimeters)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Abdominal Aortic Aneurysm Treatment Market Perspective (2019-2030)
2.2 Abdominal Aortic Aneurysm Treatment Growth Trends by Region
2.2.1 Global Abdominal Aortic Aneurysm Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Abdominal Aortic Aneurysm Treatment Historic Market Size by Region (2019-2024)
2.2.3 Abdominal Aortic Aneurysm Treatment Forecasted Market Size by Region (2025-2030)
2.3 Abdominal Aortic Aneurysm Treatment Market Dynamics
2.3.1 Abdominal Aortic Aneurysm Treatment Industry Trends
2.3.2 Abdominal Aortic Aneurysm Treatment Market Drivers
2.3.3 Abdominal Aortic Aneurysm Treatment Market Challenges
2.3.4 Abdominal Aortic Aneurysm Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Abdominal Aortic Aneurysm Treatment Players by Revenue
3.1.1 Global Top Abdominal Aortic Aneurysm Treatment Players by Revenue (2019-2024)
3.1.2 Global Abdominal Aortic Aneurysm Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Abdominal Aortic Aneurysm Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Abdominal Aortic Aneurysm Treatment Revenue
3.4 Global Abdominal Aortic Aneurysm Treatment Market Concentration Ratio
3.4.1 Global Abdominal Aortic Aneurysm Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Abdominal Aortic Aneurysm Treatment Revenue in 2023
3.5 Abdominal Aortic Aneurysm Treatment Key Players Head office and Area Served
3.6 Key Players Abdominal Aortic Aneurysm Treatment Product Solution and Service
3.7 Date of Enter into Abdominal Aortic Aneurysm Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Abdominal Aortic Aneurysm Treatment Breakdown Data by Type
4.1 Global Abdominal Aortic Aneurysm Treatment Historic Market Size by Type (2019-2024)
4.2 Global Abdominal Aortic Aneurysm Treatment Forecasted Market Size by Type (2025-2030)
5 Abdominal Aortic Aneurysm Treatment Breakdown Data by Application
5.1 Global Abdominal Aortic Aneurysm Treatment Historic Market Size by Application (2019-2024)
5.2 Global Abdominal Aortic Aneurysm Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Abdominal Aortic Aneurysm Treatment Market Size (2019-2030)
6.2 North America Abdominal Aortic Aneurysm Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Abdominal Aortic Aneurysm Treatment Market Size by Country (2019-2024)
6.4 North America Abdominal Aortic Aneurysm Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Abdominal Aortic Aneurysm Treatment Market Size (2019-2030)
7.2 Europe Abdominal Aortic Aneurysm Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Abdominal Aortic Aneurysm Treatment Market Size by Country (2019-2024)
7.4 Europe Abdominal Aortic Aneurysm Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Abdominal Aortic Aneurysm Treatment Market Size (2019-2030)
8.2 Asia-Pacific Abdominal Aortic Aneurysm Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Abdominal Aortic Aneurysm Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Abdominal Aortic Aneurysm Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Abdominal Aortic Aneurysm Treatment Market Size (2019-2030)
9.2 Latin America Abdominal Aortic Aneurysm Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Abdominal Aortic Aneurysm Treatment Market Size by Country (2019-2024)
9.4 Latin America Abdominal Aortic Aneurysm Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Abdominal Aortic Aneurysm Treatment Market Size (2019-2030)
10.2 Middle East & Africa Abdominal Aortic Aneurysm Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Abdominal Aortic Aneurysm Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Abdominal Aortic Aneurysm Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Abdominal Aortic Aneurysm Treatment Introduction
11.1.4 Abbott Revenue in Abdominal Aortic Aneurysm Treatment Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Detail
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Abdominal Aortic Aneurysm Treatment Introduction
11.2.4 AbbVie Revenue in Abdominal Aortic Aneurysm Treatment Business (2019-2024)
11.2.5 AbbVie Recent Development
11.3 Amgen
11.3.1 Amgen Company Detail
11.3.2 Amgen Business Overview
11.3.3 Amgen Abdominal Aortic Aneurysm Treatment Introduction
11.3.4 Amgen Revenue in Abdominal Aortic Aneurysm Treatment Business (2019-2024)
11.3.5 Amgen Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Abdominal Aortic Aneurysm Treatment Introduction
11.4.4 Pfizer Revenue in Abdominal Aortic Aneurysm Treatment Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Aortica
11.5.1 Aortica Company Detail
11.5.2 Aortica Business Overview
11.5.3 Aortica Abdominal Aortic Aneurysm Treatment Introduction
11.5.4 Aortica Revenue in Abdominal Aortic Aneurysm Treatment Business (2019-2024)
11.5.5 Aortica Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Detail
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Abdominal Aortic Aneurysm Treatment Introduction
11.6.4 Medtronic Revenue in Abdominal Aortic Aneurysm Treatment Business (2019-2024)
11.6.5 Medtronic Recent Development
11.7 Gore
11.7.1 Gore Company Detail
11.7.2 Gore Business Overview
11.7.3 Gore Abdominal Aortic Aneurysm Treatment Introduction
11.7.4 Gore Revenue in Abdominal Aortic Aneurysm Treatment Business (2019-2024)
11.7.5 Gore Recent Development
11.8 CVT
11.8.1 CVT Company Detail
11.8.2 CVT Business Overview
11.8.3 CVT Abdominal Aortic Aneurysm Treatment Introduction
11.8.4 CVT Revenue in Abdominal Aortic Aneurysm Treatment Business (2019-2024)
11.8.5 CVT Recent Development
11.9 Cardinal Health
11.9.1 Cardinal Health Company Detail
11.9.2 Cardinal Health Business Overview
11.9.3 Cardinal Health Abdominal Aortic Aneurysm Treatment Introduction
11.9.4 Cardinal Health Revenue in Abdominal Aortic Aneurysm Treatment Business (2019-2024)
11.9.5 Cardinal Health Recent Development
11.10 Jotec
11.10.1 Jotec Company Detail
11.10.2 Jotec Business Overview
11.10.3 Jotec Abdominal Aortic Aneurysm Treatment Introduction
11.10.4 Jotec Revenue in Abdominal Aortic Aneurysm Treatment Business (2019-2024)
11.10.5 Jotec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
